AUSUSVAR
"AUSUSVAR" is a word mark owned by Auson Pharmaceuticals Inc., filed at the USPTO on October 23, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 23, 2026
- Filed
- October 23, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50178554
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns AUSUSVAR
The owner and representative on file with the office.
Owner
Auson Pharmaceuticals Inc.
Bridgewater, United States
Representative
Christopher D. Olszyk, Jr.
Fox Rothschild LLP
What the mark covers
The products and services AUSUSVAR is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment and prevention of blood clotting, strokes, arrhythmia and other cardiac and pulmonary disorders, diseases and conditions
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About AUSUSVAR
Who owns the trademark "AUSUSVAR"?
The USPTO trademark "AUSUSVAR" (application 50178554) is owned by Auson Pharmaceuticals Inc.
What is the status of "AUSUSVAR"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull AUSUSVAR and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a16e04-0581-75af-a709-f1f5d87d1dc5
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a16e04-0581-75af-a709-f1f5d87d1dc5",
"object": "trademark",
"mark_text": "AUSUSVAR",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50178554",
"filing_date": "2026-10-23",
"nice_classes": [
5
],
"owners": [
{
"name": "Auson Pharmaceuticals Inc.",
"entity_id": null
}
]
}